Platelet activation in the pathogenesis of obesity and vascular disease

  title={Platelet activation in the pathogenesis of obesity and vascular disease},
  author={Catherine P M Hayward},
  journal={Thrombosis and Haemostasis},
  pages={567 - 568}
  • C. Hayward
  • Published 8 September 2011
  • Biology, Medicine
  • Thrombosis and Haemostasis
The pathogenesis of atherosclerotic disease is complex, and very topical, as clearly highlighted in a recent position paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology in this journal, which deals with atherosclerotic plaques and their ‘stabilisation’ per se (1). A number of associations have been observed between lipid abnormalities, markers of metabolic syndrome and platelet activation (1–5). In recent years, many studies have explored… 

The role of echocardiography in stroke risk assessment in patients with atrial fibrillation: is it additive or does it simply echo clinical risk factors?

    R. PistersJ. OlesenG. Lip
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • 2012
This editorial refers to ‘Possible refinement of clinical thromboembolism assessment in patients with atrial fibrillation using echocardiographic parameters’ by R. Providencia et al., on page 36

Brain‐Derived Neurotrophic Factor and Substrate Utilization Following Acute Aerobic Exercise in Obese Individuals

It is suggested that acute exercise‐elicited BDNF elevation may not be sufficient to modulate indices of IR or the utilization of either carbohydrates or fats in obese individuals.

Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients

P-selectin and PMP levels showed positive associations with abnormal carotid IMT and other risk factors in obesity suggesting a critical role of enhanced platelet reactivity in atherosclerotic wall alteration.

Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients

Evidence linking inflammation and thrombosis supports the hypothesis that agents with both anti-inflammatory and antiplatelet effects may reduce vascular inflammation and limit acute and long-termThrombotic events.

Metabolic syndrome, haemostasis and thrombosis

The metabolic syndrome, a concurrence of abdominal fat, disturbed glucose and insulin metabolism, dyslipidemia, and hypertension has been strongly associated not only with subsequent development of type 2 diabetes but also with athero-thrombosis.

Association Between Increased Platelet P-Selectin Expression and Obesity in Patients With Type 2 Diabetes

The results suggest that obesity and insulin resistance that accompanies obesity may influence platelet reactivity in patients with type 2 diabetes.

Platelet-vessel wall interactions in atherosclerotic disease

Summary During the prolonged course of atherosclerotic disease,platelets are of central importance as they contribute to the initiation of the disease, to its progression and acute exacerbation but

Platelet activation in obese women: role of inflammation and oxidant stress.

Android obesity is associated with enhanced lipid peroxidation and persistent platelet activation and these abnormalities are driven by inflammatory triggers related to the degree of abdominal adiposity and are, at least in part, reversible with a successful weight-loss program.

Insulin resistance as a determinant of platelet activation in obese women.

Stabilisation of atherosclerotic plaques

There is a strong biological basis and supportive clinical evidence that low-density lipoprotein lowering with statins is useful for the stabilisation of vulnerable plaques and the validity of anti-inflammatory approaches to promote plaque stability.

Platelet Counts and Platelet Activation Markers in Obese Subjects

The correlation between platelet count, platelet activation, and systemic inflammation in overweight, obese, and morbidly obese individuals was studied and obesity may be associated with elevated platelet counts in females with chronic inflammation.

Update on lipids, inflammation and atherothrombosis

Atherosclerosis is an inflammatory disease that involves the arterial wall and is characterised by the progressive accumulation of lipids in the vessel wall, which enhances the permeability of the endothelial layer and the expression of cytokines/chemokines and adhesion molecules.